US EditionCrux Emerges from Stealth with $6.5 Million in Funding, Launches First-Ever No-Cost Benefit to Make Popular Quality-of-Life Medications More Affordable
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Crux Emerges from Stealth with $6.5 Million in Funding, Launches First-Ever No-Cost Benefit to Make Popular Quality-of-Life Medications More Affordable
MCLEAN, Va.--(BUSINESS WIRE)--Crux, the first benefits platform partnering with big pharma and employers of all sizes to expand transparent and affordable access to transformative quality-of-life (QoL) medications, today announced its public launch with $6.5 million in pre-seed funding from Red Cell Partners, a venture studio that builds rapidly scalable, technology-led companies that are bringing revolutionary [...] The post Crux Emerges from S…
Crux Emerges from Stealth with $6.5 Million in Funding, Launches First-Ever No-Cost Benefit to Make Popular Quality-of-Life Medications More Affordable
MCLEAN, Va.--(BUSINESS WIRE)--Crux, the first benefits platform partnering with big pharma and employers of all sizes to expand transparent and affordable access to transformative quality-of-life (QoL) medications, today announced its public launch wit... L'articolo Crux Emerges from Stealth with $6.5 Million in Funding, Launches First-Ever No-Cost Benefit to Make Popular Quality-of-Life Medications More Affordable è un contenuto originale di 01…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
